-+ 0.00%
-+ 0.00%
-+ 0.00%

Circio Holding Signs Protein Secretion Research Collaboration with Avenue Biosciences

MT Newswires·07/16/2026 05:50:59
Listen to the news
05:50 AM EDT, 07/16/2026 (MT Newswires) -- Circio Holding (CRNA.OL) formed a research collaboration with Avenue Biosciences to improve long-term expression of secreted proteins. The Norway-listed biotechnology company, which is focused on developing novel circular RNA expression technology for gene and cell therapy, said in a Thursday release that the expression of secreted proteins is relevant for the treatment of a wide range of diseases. Avenue Biosciences will utilize its protein engineering platform to identify signal peptides that allow an improved secretion of therapeutic proteins expressed by Circio's circVec platform.